Загрузка...
Cellular Immune Responses in Humans Induced by Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines Given Separately and in Combination
MenBvac and MeNZB are safe and efficacious outer membrane vesicle (OMV) vaccines against serogroup B meningococcal disease. Antibody responses have previously been investigated in a clinical trial with these two OMV vaccines given separately (25 μg/dose) or in combination (12.5 and 12.5 μg/dose) in...
Сохранить в:
| Опубликовано в: : | Clin Vaccine Immunol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4820518/ https://ncbi.nlm.nih.gov/pubmed/26865595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00666-15 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|